| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0B | $0.9B | $0.8B | $0.8B | $0.8B | $0.7B | $0.7B | $0.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B |
| Net Income | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $2.15 | $3.26 | $0.91 | $1.77 | $1.96 | $1.97 | $1.31 | $1.36 |
| EPS (Diluted) | $2.15 | $3.25 | $0.91 | $1.77 | $1.96 | $1.97 | $0.24 | $0.32 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.7B | $5.2B | $4.6B | $3.9B | $3.6B | $3.4B | $3.1B | $2.8B |
| Current Assets | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B |
| Cash & Equivalents | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.4B | $0.5B | $0.4B | $0.3B | $0.3B | $0.6B | $0.4B | $0.3B |
| Stockholders' Equity | — | — | — | — | — | $0.9B | $0.8B | $0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.1B | $0.2B | $0.2B |
| Investing Cash Flow | $-0.5B | $-0.5B | $-0.4B | $-0.3B | $-0.3B | $-0.3B | $-0.3B | $-0.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.2B | $0.1B | $0.0B |